| Role of 5-HT in anxiety, stress and depression FG Graeff, FS Guimarães, TGC Andrade, JFW Deakin Pharmacol. Biochem. Behav 54, 129-141, 1996 | 1213* | 1996 |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães Brazilian journal of medical and biological research 39, 421-429, 2006 | 584 | 2006 |
| Animal models of anxiety disorders and stress AC Campos, MV Fogaça, DC Aguiar, FS Guimaraes Brazilian Journal of Psychiatry 35, S101-S111, 2013 | 562 | 2013 |
| Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders AC Campos, FA Moreira, FV Gomes, EA Del Bel, FS Guimaraes Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012 | 516 | 2012 |
| Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1A receptors TV Zanelati, C Biojone, FA Moreira, FS Guimarães, SRL Joca British journal of pharmacology 159 (1), 122-128, 2010 | 451 | 2010 |
| Effects of ipsapirone and cannabidiol on human experimental anxiety AW Zuardi, RA Cosme, FG Graeff, FS Guimarães Journal of psychopharmacology 7 (1_suppl), 82-88, 1993 | 438 | 1993 |
| Cannabidiol, neuroprotection and neuropsychiatric disorders AC Campos, MV Fogaça, AB Sonego, FS Guimarães Pharmacological research 112, 119-127, 2016 | 418 | 2016 |
| Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats AC Campos, FS Guimarães Psychopharmacology 199, 223-230, 2008 | 408 | 2008 |
| Antianxiety effect of cannabidiol in the elevated plus-maze FS Guimarães, TM Chiaretti, FG Graeff, AW Zuardi Psychopharmacology 100, 558-559, 1990 | 403 | 1990 |
| Antipsychotic effect of cannabidiol. AW Zuardi, SL Morais, FS Guimarães, R Mechoulam The Journal of clinical psychiatry, 1995 | 351 | 1995 |
| 5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats LBM Resstel, RF Tavares, SFS Lisboa, SRL Joca, FMA Corrêa, ... British journal of pharmacology 156 (1), 181-188, 2009 | 336 | 2009 |
| Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age JA Crippa, FS Guimarães, AC Campos, AW Zuardi Frontiers in immunology 9, 318736, 2018 | 311 | 2018 |
| The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system AC Campos, Z Ortega, J Palazuelos, MV Fogaça, DC Aguiar, ... International Journal of Neuropsychopharmacology 16 (6), 1407-1419, 2013 | 305 | 2013 |
| A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation AW Zuardi, JA Crippa, JE Hallak, S Bhattacharyya, Z Atakan, ... Curr Pharm Des 18 (32), 5131-40, 2012 | 277 | 2012 |
| Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life AW Zuardi, NP Rodrigues, AL Silva, SA Bernardo, JEC Hallak, ... Frontiers in pharmacology 8, 247580, 2017 | 271 | 2017 |
| Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test IM Linares, AW Zuardi, LC Pereira, RH Queiroz, R Mechoulam, ... Brazilian Journal of Psychiatry 41, 9-14, 2018 | 265 | 2018 |
| Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice FA Moreira, FS Guimarães European journal of pharmacology 512 (2-3), 199-205, 2005 | 247 | 2005 |
| Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test FA Moreira, DC Aguiar, FS Guimarães Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1466-1471, 2006 | 245 | 2006 |
| Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects SRL Joca, FS Guimarães Psychopharmacology 185, 298-305, 2006 | 232 | 2006 |
| Estresse, depressão e hipocampo SRL Joca, CM Padovan, FS Guimarães Brazilian Journal of Psychiatry 25, 46-51, 2003 | 212* | 2003 |
